Advance MEDTECH acquires WIKKON, consolidating its market-leading position in medical devices for urology

Advanced MedTech

Advanced MedTech

SINGAPORE, September 13, 2022 (The Globe Newswire) –

  • The acquisition provides Advanced MedTech with a medical device platform in emerging markets that aligns with China’s domestic medical device manufacturing strategy. It will serve domestic demand in China, the world’s second largest and fastest growing healthcare market, and supply other global emerging markets.

Advanced MedTech Holdings (AMTH or the group), the leading urology company, has announced its acquisition of a majority stake in WIKKON, the leading Chinese manufacturer of urology and shockwave therapy devices. AMTH expects to acquire the remaining shares of WIKKON by the end of 2022. Headquartered in the technology center in Shenzhen, also known as Silicon Valley in China, WIKKON specializes in developing and manufacturing solutions for treating urological and orthopedic conditions such as kidney stones, erectile dysfunction and joint, muscle or orthopedic pain. tissues.

Established in 1996, WIKKON has the largest installed base of more than 6000 urological devices in China and strong relationships with healthcare professionals. The acquisition will significantly enhance AMTH’s direct presence in China.

By combining the German engineering strength of Dornier MedTech, a wholly owned subsidiary of AMTH, with the innovative capabilities of WIKKON, AMTH will be able to provide clinicians with access to an expanded product portfolio and build a high-potential platform for developing the global value segment in urology.

With China’s focus on domestic sourcing of key medical devices and its large domestic market, AMTH is well positioned to meet the expanding needs of the world’s second largest and fastest growing healthcare market with deeper localization of R&D and manufacturing capabilities. WIKKON products are used in more than 40 countries in Asia Pacific and the rest of the world, giving AMTH a powerful platform to better serve the needs of global emerging markets from WIKKON’s base in Shenzhen.

Abel Ang, CEO of Advanced MedTech Group said: “We are now uniquely positioned to grow aggressively in the large Chinese market, which is best served by locally produced devices. MedTech’s integrated urology platform has been accelerated by WIKKON’s significant research and development, manufacturing, supply chain and proven unit base. Our combined portfolio will allow us to Newly serving urological clients looking for value-oriented solutions through globally discerning clients.”

Chen Ming, founder and president of WIKKON said: “We are excited to be part of the Advanced MedTech group. By combining our expertise in innovative technology, research and access, we will be able to significantly expand our solutions for healthcare professionals around the world.”


About Advanced MedTech Holdings
Advanced MedTech Holdings is a leading global medical technology company with a primary focus on urological devices and contract manufacturing services. The group serves millions of patients and doctors in 100 countries around the world. Advanced MedTech Holdings makes strategic investments in disruptive medical technology companies, enhancing its portfolio of healthcare solutions for clients around the world. Advanced MedTech Holdings is a wholly owned subsidiary of Temasek Corporation.
For more information visit

About Dornier MedTech
Dornier MedTech is a medical device company headquartered in Munich, Germany, and is a wholly owned subsidiary of Advanced MedTech. As pioneers in shock wave lithotripsy and a pioneer in urological care, Dornier is one of the most trusted names in the industry. With its steadfast spirit of entrepreneurship and excellence, Dornier continues to lead innovation in the field of urology, developing some of the highest quality urological devices on the market today. Due to its wide range of clients, Dornier leads technology and works to improve lives around the world.
For more information visit

WIKKON (Shenzhen Wikkon Precision Instruments Co., Ltd.) is a new high-tech enterprise with research, engineering and manufacturing capabilities of medical devices, headquartered in Shenzhen, China. Founded in 1996, WIKKON is dedicated to innovation in extracorporeal shock wave lithotripsy (ESWL) for kidney stone removal, extracorporeal shockwave therapy (ESWT) for erectile dysfunction and joint pain relief and urological imaging schedule for all purposes of medical examinations and procedures.
For more information visit

CONTACT: Media Contacts:  Emma Thompson / Maryanne Lee  Spurwing Communications   +65 6751 2021

Leave a Comment